Given that registered substances are allowed to circulate freely on the internal market, companies must ensure that the information contained in their registration dossiers is correct at the time of registration and that any changes to this information are reported without delay. This stems from the principle of REACH that the registrants must ensure the substances used and placed on the market do not adversely affect human health or the environment.

The REACH evaluation provisions give ECHA the responsibility to check whether registrations are in compliance with the requirements of this Regulation.

ECHA and the Member States evaluate the information submitted by companies to examine the quality of the registration dossiers and the testing proposals and to clarify if a given substance constitutes a risk to human health or the environment.

Evaluation under REACH focuses on three different areas:

  • Examination of testing proposals submitted by registrants
  • Compliance check of the dossiers submitted by registrants
  • Substance evaluation

Once the evaluation is done, registrants may be required to submit further information on the substance.